Magnetic susceptibility as a 1-year predictor of outcome in familial cerebral cavernous malformations: a pilot study
暂无分享,去创建一个
R. Pallini | A. Bianchi | E. Dejana | R. Latini | F. Triulzi | G. Conte | E. Scola | S. Lanfranconi | V. Contarino | Q. G. D’Alessandris | P. d’Orio | E. Nicolis | G. Bertani | C. Gaudino | Massimo Fusco | J. Meessen | A. Vasamì | Silvia Siggillino | Irene Incerti | Q. D’Alessandris
[1] R. Shenkar,et al. Perfusion and Permeability MRI Predicts Future Cavernous Angioma Hemorrhage and Growth , 2021, Journal of magnetic resonance imaging : JMRI.
[2] V. Torri,et al. Propranolol for familial cerebral cavernous malformation (Treat_CCM): study protocol for a randomized controlled pilot trial , 2020, Trials.
[3] Justin M. Moore,et al. Role of aspirin and statin therapy in patients with cerebral cavernous malformations , 2020, Journal of Clinical Neuroscience.
[4] C. McCulloch,et al. Effect of Simvastatin on Permeability in Cerebral Cavernous Malformation Type 1 Patients: Results from a Pilot Small Randomized Controlled Clinical Trial , 2019, Translational Stroke Research.
[5] R. Shenkar,et al. A Brain-Targeted Orally Available ROCK2 Inhibitor Benefits Mild and Aggressive Cavernous Angioma Disease , 2019, Translational Stroke Research.
[6] Richard E Thompson,et al. Quantitative susceptibility mapping as a monitoring biomarker in cerebral cavernous malformations with recent hemorrhage , 2018, Journal of magnetic resonance imaging : JMRI.
[7] T. Hirai,et al. Clinical quantitative susceptibility mapping (QSM): Biometal imaging and its emerging roles in patient care , 2017, Journal of magnetic resonance imaging : JMRI.
[8] C. Jack,et al. Population-Based Prevalence of Cerebral Cavernous Malformations in Older Adults: Mayo Clinic Study of Aging , 2017, JAMA neurology.
[9] D. Kondziolka,et al. Synopsis of Guidelines for the Clinical Management of Cerebral Cavernous Malformations: Consensus Recommendations Based on Systematic Literature Review by the Angioma Alliance Scientific Advisory Board Clinical Experts Panel , 2017, Neurosurgery.
[10] Hongjiang Wei,et al. Quantitative Susceptibility Mapping: Contrast Mechanisms and Clinical Applications , 2015, Tomography.
[11] D. Zanon,et al. Propranolol for Cerebral Cavernous Angiomatosis , 2014, Clinical pediatrics.
[12] Pascal Spincemaille,et al. Cerebral microbleeds: burden assessment by using quantitative susceptibility mapping. , 2012, Radiology.
[13] Yi Wang,et al. A novel background field removal method for MRI using projection onto dipole fields (PDF) , 2011, NMR in biomedicine.
[14] Yi Wang,et al. Quantitative susceptibility map reconstruction from MR phase data using bayesian regularization: Validation and application to brain imaging , 2010, Magnetic resonance in medicine.